Understanding Diabetic Kidney Disease (Diabetic Nephropathy)
Diabetic Kidney Disease (DKD), commonly known as diabetic nephropathy, is a progressive complication that affects up to 40% of patients with long-standing diabetes. Elevated blood glucose levels injure the delicate microvascular filters (glomeruli) within the kidneys. As the damage worsens, the kidneys leak protein (albumin) into the urine, eventually leading to a gradual loss of metabolic waste clearance.
under the expert guidance of Dr. Priyash Tambi, we implement structured, evidence-based protocols to manage diabetic nephropathy. We focus on early screening, tight glycemic and blood pressure controls, and deploying modern drugs (such as SGLT2 inhibitors and RAS blockers) to halt disease progression.
Our Diabetic Nephropathy Care Protocols Include:
- Annual microalbuminuria screening (Urine ACR) and GFR tracking
- Advanced drug therapy (SGLT2 inhibitors and ACE inhibitors/ARBs) for kidney protection
- Strict blood pressure management to reduce glomerular hyperfiltration
- Comprehensive lipid profile management and cardiovascular risk reduction
- Anemia and bone mineral metabolism screening associated with diabetic CKD
- Customized low-protein, low-sodium, diabetic-friendly nutritional counseling
Early Detection Saves Kidneys
In its early stages, diabetic kidney disease operates silently without any noticeable symptoms. Regular urinary screening is the only way to catch it early. Initiating treatment during the microalbuminuria stage can significantly reverse or delay progression, avoiding the need for future transplant or dialysis.